CEBPA and fatty liver disease: It is tempting to speculate that the elevated hepatic Th17 response of HFD-fed CD11cΔLKB1 mice contributes to worsened hepatic steatosis and insulin resistance through TRAF6-C/EBPα–mediated enhanced Cd36 expression.